Correlation Between Okta and Vytrus Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Okta and Vytrus Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Vytrus Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Vytrus Biotech SA, you can compare the effects of market volatilities on Okta and Vytrus Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Vytrus Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Vytrus Biotech.

Diversification Opportunities for Okta and Vytrus Biotech

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Okta and Vytrus is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Vytrus Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vytrus Biotech SA and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Vytrus Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vytrus Biotech SA has no effect on the direction of Okta i.e., Okta and Vytrus Biotech go up and down completely randomly.

Pair Corralation between Okta and Vytrus Biotech

Given the investment horizon of 90 days Okta is expected to generate 1.5 times less return on investment than Vytrus Biotech. But when comparing it to its historical volatility, Okta Inc is 2.37 times less risky than Vytrus Biotech. It trades about 0.02 of its potential returns per unit of risk. Vytrus Biotech SA is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  328.00  in Vytrus Biotech SA on August 31, 2024 and sell it today you would lose (110.00) from holding Vytrus Biotech SA or give up 33.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.42%
ValuesDaily Returns

Okta Inc  vs.  Vytrus Biotech SA

 Performance 
       Timeline  
Okta Inc 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Okta Inc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Okta is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Vytrus Biotech SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vytrus Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Okta and Vytrus Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Okta and Vytrus Biotech

The main advantage of trading using opposite Okta and Vytrus Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Vytrus Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vytrus Biotech will offset losses from the drop in Vytrus Biotech's long position.
The idea behind Okta Inc and Vytrus Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets